CNTX
Price
$0.55
Change
-$0.03 (-5.17%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
53.02M
42 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$2.02
Change
+$0.20 (+10.93%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
418.61M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs PROK

CNTX vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CNTX vs. PROK commentary
Jul 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2026
Stock price -- (CNTX: $0.58 vs. PROK: $1.83)
Brand notoriety: CNTX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 551% vs. PROK: 654%
Market capitalization -- CNTX: $53.02M vs. PROK: $418.61M
CNTX [@Biotechnology] is valued at $53.02M. PROK’s [@Biotechnology] market capitalization is $418.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $126.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNTX and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 2 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 2 bullish, 7 bearish.
  • PROK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а -11.00% price change this week, while PROK (@Biotechnology) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.98%. For the same industry, the average monthly price growth was -0.71%, and the average quarterly price growth was +1915.06%.

Reported Earning Dates

CNTX is expected to report earnings on Aug 12, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+0.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($419M) has a higher market cap than CNTX($53M). PROK YTD gains are higher at: -18.304 vs. CNTX (-60.544). CNTX has higher annual earnings (EBITDA): -43.5M vs. PROK (-149.81M). PROK has more cash in the bank: 225M vs. CNTX (54.5M). CNTX has less debt than PROK: CNTX (282K) vs PROK (3.78M). PROK has higher revenues than CNTX: PROK (889K) vs CNTX (0).
CNTXPROKCNTX / PROK
Capitalization53M419M13%
EBITDA-43.5M-149.81M29%
Gain YTD-60.544-18.304331%
P/E RatioN/AN/A-
Revenue0889K-
Total Cash54.5M225M24%
Total Debt282K3.78M7%
TECHNICAL ANALYSIS
Technical Analysis
CNTXPROK
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
73%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PTEZX25.39N/A
N/A
PGIM Quant Solutions Large-Cap Cor Eq Z
JDVWX29.32N/A
N/A
JHancock Disciplined Value R6
PWDCX11.89N/A
N/A
DF Tactical Dividend Fund C
HLSCX24.59N/A
N/A
Hartford Disciplined Equity HLS IC
JABIX14.24N/A
N/A
JHancock Real Estate Securities R6

CNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with ELTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then ELTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
N/A
ELTX - CNTX
50%
Loosely correlated
N/A
NMRA - CNTX
41%
Loosely correlated
N/A
TRAW - CNTX
32%
Poorly correlated
N/A
PROK - CNTX
29%
Poorly correlated
N/A
MREO - CNTX
27%
Poorly correlated
N/A
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CLDI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
N/A
CLDI - PROK
42%
Loosely correlated
+5.52%
SANA - PROK
41%
Loosely correlated
N/A
RLYB - PROK
41%
Loosely correlated
N/A
NRIX - PROK
39%
Loosely correlated
N/A
APGE - PROK
38%
Loosely correlated
N/A
More